Molecular alterations in AKT and its protein activation in human lung carcinomas

Human Pathology

Volumn 43, Issue 12, 2012, Pages 2229-2240

  Dobashi, Yoh ^a   Kimura, Maiko ^a   Matsubara, Hirochika ^b   Endo, Shunsuke ^a   Inazawa, Johji ^c   Ooi, Akishi ^d  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Activation; Akt; EGFR; Gene amplification; Lung carcinoma

Indexed keywords

AKT1 GENE; AKT2 GENE; ARTICLE; CHROMOSOME 14; CHROMOSOME 19; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE ACTIVATION; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LUNG CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PROTEIN PHOSPHORYLATION; SMALL CELL CARCINOMA;

ADULT; CARCINOMA; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84869505042     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.03.015     Document Type: Article

References (37)

1. S.P. Staal Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma Proc Natl Acad Sci U S A 84 1987 5034 5037
2. D.A. Altomare, and J.R. Testa Perturbations of the AKT signaling pathway in human cancer Oncogene 24 2005 7455 7464
3. T. Kirkegaard, C.J. Witton, and J. Edwards Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH Histopathology 56 2010 203 211
4. Y.R. Chin, and A. Toker Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer Cell Signal 21 2009 470 476
5. R.J. Shaw, and L.C. Cantley Ras, PI(3)K and mTOR signalling controls tumour cell growth Nature 441 2006 424 430
6. M.J. Arboleda, J.F. Lyons, and F.F. Kabbinavar Overexpression of AKT2/protein kinase B beta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells Cancer Res 63 2003 196 206
7. M. Vandromme, A. Rochat, and R. Meier Protein kinase B beta/Akt2 plays a specific role in muscle differentiation J Biol Chem 276 2001 8173 8179
8. P.J. Coffer, J. Jin, and J.R. Woodgett Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation Biochem J 335 Pt 1 1998 1 13
9. A. Bellacosa, C.C. Kumar, A. Di Cristofano, and J.R. Testa Activation of AKT kinases in cancer: implications for therapeutic targeting Adv Cancer Res 94 2005 29 86
10. A. Bellacosa, D. de Feo, and A.K. Godwin Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas Int J Cancer 64 1995 280 285
11. D.A. Altomare, S. Tanno, and A. De Rienzo Frequent activation of AKT2 kinase in human pancreatic carcinomas J Cell Biochem 87 2002 470 476
12. K. Nakayama, N. Nakayama, and R.J. Kurman Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms Cancer Biol Ther 5 2006 779 785
13. J. Brognard, A.S. Clark, Y. Ni, and P.A. Dennis Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation Cancer Res 61 2001 3986 3997
14. A. Shah, W.A. Swain, and D. Richardson Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer Clin Cancer Res 11 2005 2930 2936
15. Y. Dobashi, S. Suzuki, and M. Kimura Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas Hum Pathol 42 2011 214 226
16. F. Cappuzzo, E. Magrini, and G.L. Ceresoli Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer J Natl Cancer Inst 96 2004 1133 1141
17. K. Stemke-Hale, A.M. Gonzalez-Angulo, and A. Lluch An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer Cancer Res 68 2008 6084 6091
18. W. Miwa, J. Yasuda, and Y. Murakami Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer Biochem Biophys Res Commun 225 1996 968 974
19. N. Kagawa, M. Maruno, and T. Suzuki Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays Brain Tumor Pathol 23 2006 41 47
20. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tumours of the lung, pleura, thymus and heart. New York: Springer. Lyon: IARCPress, 2004.
21. P. Goldstraw, J. Crowley, and K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 706 714
22. D. Allard, N. Figg, M.R. Bennett, and T.D. Littlewood Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3 J Biol Chem 283 2008 19739 19747
23. F. Wu, S.Y. Liu, and Y.M. Tao Decreased expression of methyl methansulfonate and ultraviolet-sensitive gene clone 81 (Mus81) is correlated with a poor prognosis in patients with hepatocellular carcinoma Cancer 112 2008 2002 2010
24. F. Cappuzzo, F.R. Hirsch, and E. Rossi Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer J Natl Cancer Inst 97 2005 643 655
25. R. Hoshino, Y. Chatani, and T. Yamori Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors Oncogene 18 1999 813 822
26. A. Ooi, S. Suzuki, and K. Nakazawa Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma Anticancer Res 29 2009 19 26
27. M. Varella-Garcia Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay Diagn Pathol 1 2006 19
28. I.S. Kwon, K.H. Lee, J.W. Choi, and J.Y. Ahn PI(3,4,5)P3 regulates the interaction between Akt and B23 in the nucleus BMB Rep 43 2010 127 132
29. O. David, J. Jett, and H. LeBeau Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage Clin Cancer Res 10 2004 6865 6871
30. B.N. Ames, and L.S. Gold The causes and prevention of cancer: the role of environment Biotherapy 11 1998 205 220
31. P. Hou, M. Ji, and M. Xing Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors Cancer 113 2008 2440 2447
32. M. de Frias, D. Iglesias-Serret, and A.M. Cosialls Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells Haematologica 94 2009 1698 1707
33. L.Z. Liu, X.D. Zhou, and G. Qian AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway Cancer Res 67 2007 6325 6332
34. B.T. Hennessy, Y. Lu, and E. Poradosu Pharmacodynamic markers of perifosine efficacy Clin Cancer Res 13 2007 7421 7431
35. Y. Luo, A.R. Shoemaker, and X. Liu Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo Mol Cancer Ther 4 2005 977 986
36. C.R. Garrett, D. Coppola, and R.M. Wenham Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT Invest New Drugs 29 2011 1381 1389
37. S. Chandarlapaty, A. Sawai, and M. Scaltriti AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity Cancer Cell 19 2011 58 71